Anika Therapeutics Stock
Price
Target price
€22.60
€22.60
-3.420%
-0.8
-3.420%
€28.29
24.05.24 / Frankfurt
WKN: 889120 / Symbol: ANIK / Name: Anika / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Anika Therapeutics Stock
Anika Therapeutics took a tumble today and lost -€0.800 (-3.420%).
Our community is currently high on Anika Therapeutics with 5 Buy predictions and 0 Sell predictions.
With a target price of 28 € there is a positive potential of 23.89% for Anika Therapeutics compared to the current price of 22.6 €.
Pros and Cons of Anika Therapeutics in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Anika Therapeutics vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Anika Therapeutics | -3.420% | 0.000% | -2.500% | -6.400% | 14.706% | -33.143% | -29.835% |
Evolus Inc | 1.770% | -8.130% | 6.604% | 32.164% | 24.862% | 51.678% | - |
Ardelyx Inc. | -10.570% | -13.495% | 3.392% | 89.573% | 7.578% | 9.088% | - |
Salarius Pharmaceuticals Inc. | -4.330% | 0.971% | -2.804% | -69.412% | -25.045% | -98.384% | -99.993% |
Comments
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $37.00 price target on the stock.
Show more
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target raised by analysts at Barrington Research from $28.00 to $29.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target raised by analysts at Barrington Research from $24.00 to $28.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ANIK provided by MarketBeat